Evidence map›Paper›PMID 25435917›Full record

ReviewTherapeutic advances in urology2014

Management of priapism: an update for clinicians.

Helen R Levey, Robert L Segal, Trinity J Bivalacqua

Open access · bronzeAbstract readReview
In one paragraph

Review in Therapeutic advances in urology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 105 citations in OpenAlex.

  1. Pooled it
  2. Surgical illustrative review of the treatment of ischaemic priapism.International journal of impotence research · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. MR imaging of penile pathology and prostheses.Abdominal radiology (New York) · 2025
    Review
  9. A low-cost simulation model for priapism detumescence training.Journal of the colleges of medicine of South Africa · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. [Priapism].Urologie (Heidelberg, Germany) · 2024
    Review
  14. Review
  15. Article
  16. Article
  17. Idiopathic High-Flow Priapism.Archives of Iranian medicine · 2023
    Article
  18. Article
  19. Epidemiology and treatment of priapism in sickle cell disease.Hematology. American Society of Hematology. Education Program · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Helen R LeveyDepartment of Urology, University of Rochester Medical Center, Rochester, NY, USA.
Robert L SegalDepartment of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
Trinity J BivalacquaThe James Buchanan Brady Urological Institute, Johns Hopkins Hospital, 600 North Wolfe Avenue, Marburg 405, Baltimore, MD 21287, USA.
Johns Hopkins Hospital · USJohns Hopkins University · USUniversity of Rochester Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Priapism is a prolonged erection that persists beyond or is unrelated to sexual stimulation. It is associated with significant morbidity: psychological, socioeconomic, and physical, including pain and potentially irreversible compromise of erectile function. There are three major types of priapism: ischemic, nonischemic, and stuttering. Establishing the type of priapism is paramount to safely and effectively treating these episodes. Ischemic priapism represents a urological emergency. Its treatment may involve aspiration/irrigation with sympathomimetic injections, surgical shunts, and as a last resort, penile prosthesis implantation. Nonischemic priapism results from continuous flow of arterial blood into the penis, most commonly related to penile trauma. This is not an emergency and may be managed conservatively initially, as most of these episodes are self-limiting. Stuttering priapism involves recurrent self-limiting episodes of ischemic priapism. The primary goal of therapy is prevention, but acute episodes should be managed in accordance with guidelines for ischemic priapism. In this paper we review the diagnosis and treatment of the three priapism variants, as well as discuss future targets of therapy and novel targets on the horizon.

Indexed as

guidelinesischemicnon-ischemicpriapismrecurrentstuttering

Identifiers

PMID25435917
PMCPMC4236300
OpenAlexW2129538129

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.